226 related articles for article (PubMed ID: 6122701)
1. Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.
Lee JC; Hapel AJ; Ihle JN
J Immunol; 1982 Jun; 128(6):2393-8. PubMed ID: 6122701
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 production by lymphoid cells from congenitally athymic (nu/nu) mice.
MacDonald HR; Lees RK; Glasebrook AL; Sordat B
J Immunol; 1982 Aug; 129(2):521-5. PubMed ID: 6123534
[TBL] [Abstract][Full Text] [Related]
3. Development and continuous growth in culture of interleukin 2-producer lymphocytes from athymic nu/nu mice.
Palacios R; Fernandez C; Sideras P
Eur J Immunol; 1982 Sep; 12(9):777-82. PubMed ID: 6982822
[TBL] [Abstract][Full Text] [Related]
4. Biologic properties of interleukin 3. II. Serologic comparison of 20-alpha-SDH-inducing activity, colony-stimulating activity, and WEHI-3 growth factor activity by using an antiserum against IL 3.
Bowlin TL; Scott AN; Ihle JN
J Immunol; 1984 Oct; 133(4):2001-6. PubMed ID: 6432905
[TBL] [Abstract][Full Text] [Related]
5. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
Ihle JN; Lee JC; Rebar L
J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
[TBL] [Abstract][Full Text] [Related]
6. Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine.
Ihle JN; Pepersack L; Rebar L
J Immunol; 1981 Jun; 126(6):2184-9. PubMed ID: 6971890
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characteristics of cell lines requiring interleukin 3 for growth.
Ihle JN; Keller J; Greenberger JS; Henderson L; Yetter RA; Morse HC
J Immunol; 1982 Oct; 129(4):1377-83. PubMed ID: 6809821
[TBL] [Abstract][Full Text] [Related]
8. Interleukins 2 and 3 regulate the in vitro proliferation of two distinguishable populations of 20-alpha-hydroxysteroid dehydrogenase-positive cells.
Keller JR; Weinstein Y; Hursey M; Ihle JN
J Immunol; 1985 Sep; 135(3):1864-71. PubMed ID: 2862209
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
Gillis S; Scheid M; Watson J
J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
[TBL] [Abstract][Full Text] [Related]
10. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
Orosz CG; Zinn NE; Olsen RG; Mathes LE
J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
13. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.
Ihle JN; Keller J; Oroszlan S; Henderson LE; Copeland TD; Fitch F; Prystowsky MB; Goldwasser E; Schrader JW; Palaszynski E; Dy M; Lebel B
J Immunol; 1983 Jul; 131(1):282-7. PubMed ID: 6190911
[TBL] [Abstract][Full Text] [Related]
14. Constitutive production of interleukin 2 activity by a T cell hybridoma.
Stull D; Gillis S
J Immunol; 1981 May; 126(5):1680-3. PubMed ID: 6971310
[TBL] [Abstract][Full Text] [Related]
15. The effects of sodium butyrate on lymphokine production.
Le Gros GS; Herbert AG; Watson JD
Lymphokine Res; 1985; 4(3):221-7. PubMed ID: 3928980
[TBL] [Abstract][Full Text] [Related]
16. Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors.
Schmitt E; Van Brandwijk R; Fischer HG; Rüde E
Eur J Immunol; 1990 Aug; 20(8):1709-15. PubMed ID: 2120063
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive cloned T cell lines. VII. Comparison of the kinetics of IL 2 release stimulated by alloantigen or Con A.
Ely JM; Fitch FW
J Immunol; 1983 Sep; 131(3):1274-9. PubMed ID: 6604092
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.
Kern DE; Gillis S; Okada M; Henney CS
J Immunol; 1981 Oct; 127(4):1323-8. PubMed ID: 6456304
[TBL] [Abstract][Full Text] [Related]
19. Purification of murine helper T cell-replacing factors.
Watson J; Mochizuki D; Gillis S
Prog Clin Biol Res; 1981; 66 Pt A():513-22. PubMed ID: 6975944
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
